A Phase II Trial of Organoid Drug Sensitivity Testing to Guide Therapy in Unresectable Biliary Tract Cancers

by | Jan 20, 2026 | Clinical Trials | 0 comments

​ Conditions: Advanced Biliary Tract Cancer(BTC)

Interventions: Drug: Organoid Drug Sensitivity Testing-Guided Therapy

Sponsors: Eastern Hepatobiliary Surgery Hospital

Not yet recruiting Conditions: Advanced Biliary Tract Cancer(BTC)
Interventions: Drug: Organoid Drug Sensitivity Testing-Guided Therapy
Sponsors: Eastern Hepatobiliary Surgery Hospital
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *